Associated Banc Corp Novartis Ag Transaction History

Associated Banc Corp

$3.19 Billion
Q4 2024

A detailed history of Associated Banc Corp transactions in Novartis Ag stock. As of the latest transaction made, Associated Banc Corp holds 8,490 shares of NVS stock, worth $907,665. This represents 0.03% of its overall portfolio holdings.

Number of Shares

8,490

Previous 8,812 3.65%

Holding current value

$907,665

Previous $1.01 Million 18.46%

% of portfolio

0.03%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$96.78 - $117.18 $31,163 - $37,731	-322 Reduced 3.65%	8,490 $826,000
Q3 2024 Nov 13, 2024	SELL	$106.13 - $120.89 $4,245 - $4,835	-40 Reduced 0.45%	8,812 $1.01 Million
Q2 2024 Aug 01, 2024	BUY	$92.57 - $107.37 $12,404 - $14,387	134 Added 1.54%	8,852 $942,000
Q1 2024 May 09, 2024	SELL	$95.27 - $108.47 $9,812 - $11,172	-103 Reduced 1.17%	8,718 $843,000
Q4 2023 Feb 09, 2024	SELL	$92.27 - $101.54 $20,391 - $22,440	-221 Reduced 2.44%	8,821 $890,000
Q3 2023 Nov 09, 2023	SELL	$94.73 - $105.13 $22,735 - $25,231	-240 Reduced 2.59%	9,042 $921,000
Q2 2023 Aug 07, 2023	SELL	$92.52 - $104.91 $7,216 - $8,182	-78 Reduced 0.83%	9,282 $936,000
Q1 2023 May 09, 2023	BUY	$80.03 - $92.81 $14,805 - $17,169	185 Added 2.02%	9,360 $861,000
Q4 2022 Feb 10, 2023	BUY	$75.55 - $92.52 $2,039 - $2,498	27 Added 0.3%	9,175 $832,000
Q3 2022 Nov 09, 2022	SELL	$74.61 - $87.26 $16,041 - $18,760	-215 Reduced 2.3%	9,148 $695,000
Q2 2022 Aug 10, 2022	SELL	$80.52 - $93.75 $34,704 - $40,406	-431 Reduced 4.4%	9,363 $792,000
Q1 2022 May 11, 2022	SELL	$80.11 - $90.62 $33,966 - $38,422	-424 Reduced 4.15%	9,794 $859,000
Q4 2021 Feb 10, 2022	SELL	$79.7 - $88.13 $9,962 - $11,016	-125 Reduced 1.21%	10,218 $894,000
Q3 2021 Nov 08, 2021	SELL	$81.78 - $95.14 $29,113 - $33,869	-356 Reduced 3.33%	10,343 $845,000
Q2 2021 Aug 11, 2021	SELL	$85.24 - $94.15 $145,163 - $160,337	-1,703 Reduced 13.73%	10,699 $977,000
Q1 2021 May 05, 2021	BUY	$83.5 - $98.47 $73,062 - $86,161	875 Added 7.59%	12,402 $1.02 Million
Q4 2020 Feb 11, 2021	SELL	$78.07 - $94.43 $20,844 - $25,212	-267 Reduced 2.26%	11,527 $1.09 Million
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $57,169 - $63,336	-696 Reduced 5.57%	11,794 $1.03 Million
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $1,618 - $1,822	-20 Reduced 0.16%	12,490 $1.09 Million
Q1 2020 May 14, 2020	BUY	$70.67 - $99.01 $75,616 - $105,940	1,070 Added 9.35%	12,510 $1.03 Million
Q4 2019 Feb 12, 2020	SELL	$84.35 - $95.37 $9,700 - $10,967	-115 Reduced 1.0%	11,440 $1.08 Million
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $55,943 - $61,646	-654 Reduced 5.36%	11,555 $1 Million
Q2 2019 Aug 06, 2019	SELL	$75.4 - $92.8 $50,065 - $61,619	-664 Reduced 5.16%	12,209 $1.12 Million
Q1 2019 May 07, 2019	SELL	$75.32 - $86.15 $14,310 - $16,368	-190 Reduced 1.45%	12,873 $1.24 Million
Q4 2018 Feb 13, 2019	BUY	$73.66 - $82.02 $7,586 - $8,448	103 Added 0.79%	13,063 $1.12 Million
Q3 2018 Nov 07, 2018	SELL	$66.94 - $77.43 $667,525 - $772,131	-9,972 Reduced 43.49%	12,960 $1.12 Million
Q2 2018 Aug 07, 2018	BUY	$64.91 - $73.36 $1.49 Million - $1.68 Million	22,932 New	22,932 $1.73 Million

Others Institutions Holding NVS

# of Institutions

1,472

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $230B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Associated Banc Corp, based on Form 13F filings with the SEC.

News

Stay updated on Associated Banc Corp with notifications on news.

Account

Associated Banc Corp Novartis Ag Transaction History